407 results on '"Shumack, Stephen"'
Search Results
2. Risankizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study
3. Position statement: balancing the harms and benefits of sun exposure
4. Cross‐sectional burden‐of‐illness study in atopic dermatitis (MEASURE‐AD) in Australia and New Zealand reveals impacts on well‐being
5. Actinic keratosis: An update on management.
6. Minimum labelling requirements for dermatology artificial intelligence‐based Software as Medical Device (SaMD): A consensus statement
7. Deucravacitinib: A first-in-class oral treatment for psoriasis.
8. Efficacy and safety analysis: 24‐month outcomes from a prospective cohort of 106 fields treated with widefield radiation therapy for extensive skin field cancerization, with or without keratinocyte cancers.
9. Rosacea Core Domain Set for Clinical Trials and Practice: A Consensus Statement
10. The role of micrometastasis in high‐risk skin cancers.
11. Real‐world clinical, psychosocial and economic burden of atopic dermatitis: Results from a multicountry study.
12. Real‐world clinical, psychosocial and economic burden of atopic dermatitis: Results from a multicountry study
13. Clinical photography of skin lesions: 'Professional and legal considerations in primary care'
14. The Treat-to-Target Project in Atopic Dermatitis: One Year On
15. The Treat-to-Target Project in Atopic Dermatitis:One Year On
16. Australian consensus: Treatment goals for moderate to severe psoriasis in the era of targeted therapies – Adult patients.
17. Abrocitinib in the Treatment of Moderate-to-Severe Atopic Dermatitis Refractory to Dupilumab Treatment: An Analysis of JADE-EXTEND, a Phase 3 Long-Term Extension Study
18. Metastatic squamous cell carcinoma in chronic lymphocytic leukaemia in a haematology–dermatology multidisciplinary clinic
19. Basal Cell Carcinoma
20. Informing a position statement on the use of artificial intelligence in dermatology in Australia
21. Dupilumab‐associated ocular surface disease: An interdisciplinary decision framework for prescribers in the Australian setting
22. Phase 3 efficacy and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis after switching from dupilumab (JADE EXTEND)
23. Systemic Chemoprevention
24. Mucinous Naevus: A case of suboptimal response to laser treatment
25. Successful use of Brutonʼs kinase inhibitor, ibrutinib, to control paraneoplastic pemphigus in a patient with paraneoplastic autoimmune multiorgan syndrome and chronic lymphocytic leukaemia
26. Actinic keratosis An update on management.
27. Method of Assessing Skin Cancerization and KeratosesTM (MASCK™): development and photographic validation in multiple anatomical sites of a novel assessment tool intended for clinical evaluation of patients with extensive skin field cancerization
28. Successful management of Australian patients with extensive skin field cancerization (ESFC) with widefield volumetric arc radiation therapy (VMAT): Report with 12-month follow-up.
29. Development of melanoma clinical quality indicators for the Australian melanoma clinical outcomes registry ( MelCOR ): A modified Delphi study
30. Specialty Practice Series: Atopic Dermatitis - Barrier Function and Treatment
31. Informing a position statement on the use of artificial intelligence in dermatology in Australia.
32. Association between vitiligo and risk of suicide and suicidal ideation: systematic review and meta-analysis
33. Second primary malignancies in chronic lymphocytic leukaemia: Skin, solid organ, haematological and Richter's syndrome
34. Is the contribution of Australian research to the national 2019 clinical practice guidelines for keratinocyte cancer adequate? A simple analysis
35. Consensus-Based Recommendations on the Prevention of Squamous Cell Carcinoma in Solid Organ Transplant Recipients
36. Actinic Keratosis: Rationale and Management
37. Treatment of face and scalp solar (actinic) keratosis with daylight-mediated photodynamic therapy is possible throughout the year in Australia: Evidence from a clinical and meteorological study
38. An introduction to field therapies for photoageing.
39. Tribute to Reviewers
40. Recruitment of adults with moderate eczema for a randomised trial: Comparison of traditional versus modern methods
41. 27590 Abrocitinib in the treatment of moderate-to-severe atopic dermatitis refractory to dupilumab treatment: An analysis of JADE-EXTEND, a phase 3 long-term extension study
42. Efficacy and safety of methyl-aminolevulinate cream activated by daylight in actinic keratosis: Two randomized, investigator blinded, controlled, phase 3 studies in Europe and Australia: 858
43. Treat-to-Target in Atopic Dermatitis: An International Consensus on a Set of Core Decision Points for Systemic Therapies
44. Preliminary efficacy and safety analysis: 12-month results in 83 patients using a novel approach of widefield radiation therapy for extensive skin field cancerization with or without keratinocyte cancers.
45. A daily regimen of a ceramide‐dominant moisturizing cream and cleanser restores the skin permeability barrier in adults with moderate eczema: A randomized trial
46. Method of Assessing Skin Cancerization and KeratosesTM (MASCK™): development and photographic validation in multiple anatomical sites of a novel assessment tool intended for clinical evaluation of patients with extensive skin field cancerization
47. Field-based radiotherapy using volumetric modulated arc therapy (VMAT) for skin field cancerisation (SFC)–outcomes from 100 consecutive fields
48. Teledermatology Can Produce High-Quality Care at Low Cost
49. Long-term Follow-up Study of Ingenol Mebutate Gel for the Treatment of Actinic Keratoses
50. Letter to the Editor
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.